Canada· CA-DIN-02139502

VASOPRESSIN INJECTION, USP

A vasopressin (argipressin) product containing vasopressin, registered in Canada by FRESENIUS KABI CANADA LTD. The same ATC class is registered in 10 of our 19 countries.

ATC H01BA01

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about vasopressinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Vasopressin (argipressin) is registered in 10 of 19 countries.

Countries holding a registration under ATC H01BA01 (vasopressin (argipressin)), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
6 of them publish a price we can compare per daily dose

Search vasopressin (argipressin) products by name

Vasopressin (argipressin) · ATC H01BA01

10 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: VASOPRESSIN
Manufacturer: FRESENIUS KABI CANADA LTD
Country: Canada (CA)
ATC code: H01BA01
ATC class: Vasopressin (argipressin)
Defined daily dose: 40 E, P
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

166 interactions on record for vasopressin (argipressin).

Graded by severity as the source publishes them — 39 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check vasopressin (argipressin) against other medicines How interaction checks work

Vasopressin (argipressin) · interactions on record

166 records

39 severe
125 moderate
2 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
PapaverinC04AX38severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vasopressin (argipressin) in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vasopressin (argipressin) products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Empesin
Belgium · Reverpleg
Bulgaria · Емпресин
Czechia · Embesin
Germany · Argipressin Farmak, Empressin
Denmark · Empressin
Estonia · Empesin
Spain · Empressin
Finland · Empressin
France · Reverpleg
United Kingdom (Northern Ireland) · Argipressin Aop, Argipressin Mercury Pharmaceuticals
Greece · Empressin
Croatia · Empressin
Hungary · Embesyn
Ireland · Embesin
Italy · Empressin
Lithuania · Empesin
Luxembourg · Reverpleg
Latvia · Empesin
Netherlands · Empressine
Norway · Empressin
Poland · Argipressin Farmak, Empesin
Portugal · Empressin
Romania · Reverpleg
Sweden · Empressin
Slovenia · Empesin
Slovakia · Embesin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bbfe4a23-2bda-4533-9bc2-ac84a943d200
GET /v1/drugs/bbfe4a23-2bda-4533-9bc2-ac84a943d200?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02139502",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "SUBCUTANEOUS",
    "INTRAMUSCULAR"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "H01BA01",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "31359",
  "strengths": [
    "20 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "VASOPRESSIN"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about vasopressin (argipressin).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console